These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8801507)

  • 1. An overview of bladder cancer: treatment and nursing implications.
    Kelly LP; Miaskowski C
    Oncol Nurs Forum; 1996 Apr; 23(3):459-68. PubMed ID: 8801507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small cell lung cancer: pathophysiologic mechanisms and nursing implications.
    Glover J; Miaskowski C
    Oncol Nurs Forum; 1994; 21(1):87-95; quiz 96-7. PubMed ID: 8140007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
    Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
    Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base.
    David KA; Milowsky MI; Ritchey J; Carroll PR; Nanus DM
    J Urol; 2007 Aug; 178(2):451-4. PubMed ID: 17561135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical panurothelial disease in patients with superficial bladder tumors: therapeutic implications.
    Solsona E; Iborra I; Ricos JV; Monros JL; Rubio J; Almenar S
    J Urol; 2002 May; 167(5):2007-11. PubMed ID: 11956428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer.
    Gofrit ON; Shapiro A; Pode D; Sidi A; Nativ O; Leib Z; Witjes JA; van der Heijden AG; Naspro R; Colombo R
    Urology; 2004 Mar; 63(3):466-71. PubMed ID: 15028439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M
    Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer of the prostate: treatment and nursing implications.
    Held JL; Osborne DM; Volpe H; Waldman AR
    Oncol Nurs Forum; 1994 Oct; 21(9):1517-29. PubMed ID: 7816678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bladder and upper tract urothelial cancer.
    Konety BR; Joyce GF; Wise M
    J Urol; 2007 May; 177(5):1636-45. PubMed ID: 17437776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An organ-sparing treatment using combined intra-arterial chemotherapy and radiotherapy for muscle-invading bladder carcinoma.
    Tsukamoto S; Ishikawa S; Tsutsumi M; Nakajima K; Sugahara S
    Scand J Urol Nephrol; 2002; 36(5):339-43. PubMed ID: 12487737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of bladder cancer: a nursing view.
    Roodhouse A
    Prof Nurse; 2000 Dec; 16(3):987-90. PubMed ID: 12029884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of long-term treatment of inoperable cancer of the bladder with cisplatin and concurrent irradiation: prognostic factors of local control and survival].
    Chauvet B; Félix-Faure C; Davin JL; Choquenet C; Alfonsi M; Reboul F
    Cancer Radiother; 1998 Apr; 2 Suppl 1():85s-91s. PubMed ID: 9749086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update of combined modality therapy for patients with muscle invading bladder cancer using selective bladder preservation or cystectomy.
    Shipley WU; Kaufman DS; Heney NM; Althausen AF; Zietman AL
    J Urol; 1999 Aug; 162(2):445-50; discussion 450-1. PubMed ID: 10411054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bladder conservation treatment in the elderly population: results and prognostic factors of muscle-invasive bladder cancer.
    Tran E; Souhami L; Tanguay S; Rajan R
    Am J Clin Oncol; 2009 Aug; 32(4):333-7. PubMed ID: 19381080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The treated natural history of high risk superficial bladder cancer: 15-year outcome.
    Cookson MS; Herr HW; Zhang ZF; Soloway S; Sogani PC; Fair WR
    J Urol; 1997 Jul; 158(1):62-7. PubMed ID: 9186324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cyclooxygenase-2-expression in bladder cancer: tumor-biological and clinical implications].
    Wülfing C; Eltze E; Von Struensee D; Wülfing P; Bode ME; Bettendorf O; Piechota H; Hertle L
    Aktuelle Urol; 2004 Aug; 35(4):331-8. PubMed ID: 15459875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravesical antineoplastic therapy following transurethral resection of bladder tumors: nursing implications from the operating room to discharge.
    Washburn DJ
    Clin J Oncol Nurs; 2007 Aug; 11(4):553-9. PubMed ID: 17723968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bladder cancer.
    Ozen H
    Curr Opin Oncol; 1998 May; 10(3):273-8. PubMed ID: 9619365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of superficial recurrences in an irradiated bladder after combined-modality organ-preserving therapy.
    Weiss C; Wittlinger M; Engehausen DG; Krause FS; Ott OJ; Dunst J; Sauer R; Rödel C
    Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1502-6. PubMed ID: 17935905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bladder cancer.
    Gwynn ES; Clark PE
    Curr Opin Oncol; 2006 May; 18(3):277-83. PubMed ID: 16552241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.